Cannabidiol (CBD) Cannabinoid Research

Cannabidiol (CBD) Research Dashboard

515

Primary Studies

97

Related Studies

612

Total Studies

Clinical Studies

57

Double-blind human trials

44

Clinical human trials

Pre-Clinical Studies

169

Meta-analyses/Reviews

169

Animal studies

74

Laboratory studies

What am I missing as a non-subscriber?

To see a full dashboard with study details and filtering, go to our DEMO page.

As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.

CannaKeys has 612 studies associated with Cannabidiol (CBD).

Here is a small sampling of Cannabidiol (CBD) studies by title:


Components of the Cannabidiol (CBD) Research Dashboard

  • Top medical conditions associated with Cannabidiol (CBD)
  • Proven effects in clinical trials for Cannabidiol (CBD)
  • Receptors associated with Cannabidiol (CBD)
  • Individual study details for Cannabidiol (CBD)

Ready to become a subscriber? Go to our PRICING page.

Select New Cannabinoid

Filter Cannabinoid

Members can filter by the following criteria:

  • Study Type
  • Organ Systems
  • Terpenes
  • Receptors
  • Ligands
  • Study Result
  • Year of Publication

Overview - Cannabidiol (CBD)

Description of Cannabidiol (CBD)

The plant-based (phytocannabinoid) CBD was discovered in 1940. By 2016 there were a total of 10 members in the CBD family. CBD is a major cannabinoid that occurs naturally in cannabis in amounts large enough to produce various and significant changes in the human body, mind, and emotions.

Other Names:

Cannabidiol

Cannabidiol (CBD) Properties and Effects

CBD is, like THC, a multi-target molecule that binds with numerous cell receptors throughout the body; thus it directly and indirectly initiates complex biological changes. One study highlighted more than 30 pharmacological actions for CBD which may be therapeutically relevant to a number of conditions including Alzheimer's Disease, Parkinson's Disease, neuropathies, bacterial infections (MRSA), cancer, or acne.

Cannabidiol (CBD) Receptor Binding

Very weak affinity for CB1 (Ki for CB1 is 1459nM

Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.